{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:13:56Z","timestamp":1783426436568,"version":"3.54.6"},"reference-count":20,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"unspecified","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011326","name":"Shiga University of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,6,26]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>A woman in her late 70s presented with progressive limb weakness, muscle atrophy and hyper-reflexia. Laboratory findings revealed elevated creatine kinase and positive serum human T-cell leukaemia virus type 1 (HTLV-1) antibody. Clinical and electrophysiological findings met revised El Escorial criteria for amyotrophic lateral sclerosis (ALS), but muscle MRI showed inflammatory changes. Muscle biopsy revealed both neurogenic and inflammatory features. While methylprednisolone showed no benefit, intravenous immunoglobulin therapy produced transient improvement in weakness with normalisation of creatine kinase levels. The patient died from respiratory failure 3 years after symptom onset. Autopsy confirmed typical ALS-TDP pathology with phosphorylated TDP-43 inclusions in motor neurons. HTLV-1 Tax-positive lymphocytes infiltrated skeletal muscles but not the central nervous system, establishing dual pathology of ALS-TDP with HTLV-1-associated myositis. The improvement most likely reflected treatment of the HTLV-1-associated myositis rather than the underlying motor neuron disease. This case highlights the importance of evaluating treatable conditions in HTLV-1-seropositive ALS patients.<\/jats:p>","DOI":"10.1136\/bcr-2025-270944","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:17:51Z","timestamp":1783423071000},"page":"e270944","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Case of concurrent ALS and human T-cell leukaemia virus type 1-associated myositis"],"prefix":"10.1136","volume":"19","author":[{"given":"Toshika","family":"Hata","sequence":"first","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yabata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Kobashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Pathology, Shiga University of Medical Science, Otsu, Shiga Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Ishigaki","sequence":"additional","affiliation":[{"name":"Division of Pathology and Disease Regulation, Shiga University of Medical Science, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"Neurology, Shiga University of Medical Science, Otsu, Shiga Prefecture, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Itoh","sequence":"additional","affiliation":[{"name":"Division of Pathology and Disease Regulation, Shiga University of Medical Science, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Research, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2773-9836","authenticated-orcid":false,"given":"Makoto","family":"Urushitani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2026070704150911000_19.7.e270944.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1603471"},{"key":"2026070704150911000_19.7.e270944.2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaneurol.2022.0901","article-title":"Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial","volume":"79","author":"Oki","year":"2022","journal-title":"JAMA Neurol"},{"key":"2026070704150911000_19.7.e270944.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204705"},{"key":"2026070704150911000_19.7.e270944.4","doi-asserted-by":"publisher","DOI":"10.1007\/BF02444000"},{"key":"2026070704150911000_19.7.e270944.5","doi-asserted-by":"crossref","DOI":"10.1007\/s11908-014-0459-0","article-title":"Update on Neurological Manifestations of HTLV-1 Infection","volume":"17","author":"Araujo","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"2026070704150911000_19.7.e270944.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61245-X"},{"key":"2026070704150911000_19.7.e270944.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.05.006"},{"key":"2026070704150911000_19.7.e270944.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70628-7"},{"key":"2026070704150911000_19.7.e270944.9","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(93)90111-3"},{"key":"2026070704150911000_19.7.e270944.10","doi-asserted-by":"crossref","first-page":"1547712","DOI":"10.3389\/fmed.2025.1547712","article-title":"HTLV-1 and HTLV-2 infections significantly alter small RNA expression in asymptomatic carriers","volume":"12","author":"Fernandes","year":"2025","journal-title":"Front Med"},{"key":"2026070704150911000_19.7.e270944.11","article-title":"Human T-cell Lymphotropic Virus Type I Associated with Amyotrophic Lateral Sclerosis Syndrome: Immunopathological Aspects and Treatment Options","volume":"12","author":"Gonzalez Trujillo","year":"2020","journal-title":"Cureus"},{"key":"2026070704150911000_19.7.e270944.12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3109\/13550280009091955","article-title":"HTLV-I-associated myelopathy (HAM)\/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations","volume":"6","author":"Matsuzaki","year":"2000","journal-title":"J Neurovirol"},{"key":"2026070704150911000_19.7.e270944.13","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(91)90258-9"},{"key":"2026070704150911000_19.7.e270944.14","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000180962.47653.5e"},{"key":"2026070704150911000_19.7.e270944.15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/BOR.0000000000000975","article-title":"Update on muscle imaging in myositis","volume":"35","author":"Tan","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"2026070704150911000_19.7.e270944.16","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.966690"},{"key":"2026070704150911000_19.7.e270944.17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1590\/S0004-282X1993000300005","article-title":"Intravenous methylprednisolone in HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"51","author":"Ara\u00fajo","year":"1993","journal-title":"Arq Neuropsiquiatr"},{"key":"2026070704150911000_19.7.e270944.18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00315327","article-title":"Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin","volume":"238","author":"Kuroda","year":"1991","journal-title":"J Neurol"},{"key":"2026070704150911000_19.7.e270944.19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0404.1995.tb01689.x","article-title":"Clinical characteristics of HTLV-1 associated dermato-polymyositis. Seven cases from Martinique","volume":"92","author":"Smadja","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"2026070704150911000_19.7.e270944.20","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2001.104002101.x"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-270944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:17:53Z","timestamp":1783423073000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-270944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,7]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bcr-2025-270944"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-270944","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}